Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123013255 | 12301325 | 5 | F | 20160630 | 20160425 | 20160705 | EXP | CA-PFIZER INC-2014360295 | PFIZER | 64.00 | YR | F | Y | 85.00000 | KG | 20160705 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123013255 | 12301325 | 1 | SS | ENBREL | ETANERCEPT | 1 | UNK | N | 0 | ||||||||||
123013255 | 12301325 | 2 | SS | ENBREL | ETANERCEPT | 1 | N | 0 | |||||||||||
123013255 | 12301325 | 3 | SS | ENBREL | ETANERCEPT | 1 | N | 0 | |||||||||||
123013255 | 12301325 | 4 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | BETWEEN 17.5 MG AND 25MG, WEEKLY | N | 11719 | 17.5 | MG | /wk | |||||||
123013255 | 12301325 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | N | 11719 | ||||||||||
123013255 | 12301325 | 6 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | N | 11719 | |||||||||||
123013255 | 12301325 | 7 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 2 G, DAILY | N | 7073 | 2 | G | |||||||
123013255 | 12301325 | 8 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | N | 7073 | |||||||||||
123013255 | 12301325 | 9 | SS | HUMIRA | ADALIMUMAB | 1 | UNK | N | 0 | ||||||||||
123013255 | 12301325 | 10 | SS | HUMIRA | ADALIMUMAB | 1 | N | 0 | |||||||||||
123013255 | 12301325 | 11 | SS | ORENCIA | ABATACEPT | 1 | UNK | N | 0 | ||||||||||
123013255 | 12301325 | 12 | SS | ORENCIA | ABATACEPT | 1 | N | 0 | |||||||||||
123013255 | 12301325 | 13 | SS | ARAVA | LEFLUNOMIDE | 1 | 20 MG, 1X/DAY | N | 0 | 20 | MG | TABLET | QD | ||||||
123013255 | 12301325 | 14 | SS | ARAVA | LEFLUNOMIDE | 1 | N | 0 | TABLET | ||||||||||
123013255 | 12301325 | 15 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 400 MG, 1X/DAY | N | 0 | 400 | MG | TABLET | QD | ||||||
123013255 | 12301325 | 16 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | N | 0 | TABLET | |||||||||
123013255 | 12301325 | 17 | SS | TRAMCET | ACETAMINOPHENTRAMADOL | 1 | UNK | U | 0 | TABLET | |||||||||
123013255 | 12301325 | 18 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK, SINGLE | N | 0 | |||||||||
123013255 | 12301325 | 19 | C | NORTRIPTYLIN | NORTRIPTYLINE | 1 | 20 MG, 1X/DAY AT BEDTIME (2 TABLETS PER DAY) | 0 | 20 | MG | QD | ||||||||
123013255 | 12301325 | 20 | C | NORTRIPTYLIN | NORTRIPTYLINE | 1 | 0 | ||||||||||||
123013255 | 12301325 | 21 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 500 MG, 2X/DAY | 0 | 500 | MG | BID | ||||||||
123013255 | 12301325 | 22 | C | LORAZEPAM. | LORAZEPAM | 1 | 1 MG, 1X/DAY NIGHTLY | 0 | 1 | MG | QD | ||||||||
123013255 | 12301325 | 23 | C | VAGIFEM | ESTRADIOL | 1 | UNK | 0 | |||||||||||
123013255 | 12301325 | 24 | C | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | 0 | 150 | MG | CAPSULE | BID | ||||||
123013255 | 12301325 | 25 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | 0.625 MG, UNK | 0 | .625 | MG | VAGINAL CREAM | ||||||||
123013255 | 12301325 | 26 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
123013255 | 12301325 | 27 | C | CALCIUM | CALCIUM | 1 | UNK | 0 | |||||||||||
123013255 | 12301325 | 28 | C | DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | 1 | Subcutaneous | 40 MG, MONTHLY | 0 | 40 | MG | INJECTION | /month | ||||||
123013255 | 12301325 | 29 | C | DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | 1 | 0 | INJECTION | |||||||||||
123013255 | 12301325 | 30 | C | TYLENOL ARTHRITIS PAIN | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
123013255 | 12301325 | 31 | C | ACTONEL | RISEDRONATE SODIUM | 1 | 35 MG, WEEKLY | 0 | 35 | MG | /wk | ||||||||
123013255 | 12301325 | 32 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | UNK | 0 | |||||||||||
123013255 | 12301325 | 33 | C | METHYLPREDNISOLONE ACETATE. | METHYLPREDNISOLONE ACETATE | 1 | Intramuscular | 40 MG, 1 EVERY 1 MONTH | 0 | 40 | MG | /month | |||||||
123013255 | 12301325 | 34 | C | NORTRIPTYLINE HYDROCHLORIDE. | NORTRIPTYLINE HYDROCHLORIDE | 1 | 20 MG, QD | 0 | 20 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123013255 | 12301325 | 1 | Rheumatoid arthritis |
123013255 | 12301325 | 2 | Spinal osteoarthritis |
123013255 | 12301325 | 3 | Rheumatoid arthritis |
123013255 | 12301325 | 4 | Rheumatoid arthritis |
123013255 | 12301325 | 5 | Spinal osteoarthritis |
123013255 | 12301325 | 6 | Rheumatoid arthritis |
123013255 | 12301325 | 7 | Rheumatoid arthritis |
123013255 | 12301325 | 8 | Rheumatoid arthritis |
123013255 | 12301325 | 9 | Rheumatoid arthritis |
123013255 | 12301325 | 10 | Spinal osteoarthritis |
123013255 | 12301325 | 11 | Rheumatoid arthritis |
123013255 | 12301325 | 12 | Spinal osteoarthritis |
123013255 | 12301325 | 13 | Rheumatoid arthritis |
123013255 | 12301325 | 14 | Spinal osteoarthritis |
123013255 | 12301325 | 15 | Rheumatoid arthritis |
123013255 | 12301325 | 16 | Spinal osteoarthritis |
123013255 | 12301325 | 17 | Rheumatoid arthritis |
123013255 | 12301325 | 18 | Rheumatoid arthritis |
123013255 | 12301325 | 19 | Pain |
123013255 | 12301325 | 20 | Sleep disorder |
123013255 | 12301325 | 21 | Type 2 diabetes mellitus |
123013255 | 12301325 | 24 | Pain |
123013255 | 12301325 | 28 | Pain |
123013255 | 12301325 | 29 | Sleep disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123013255 | 12301325 | HO |
123013255 | 12301325 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123013255 | 12301325 | Back pain | |
123013255 | 12301325 | Carpal tunnel syndrome | |
123013255 | 12301325 | Condition aggravated | |
123013255 | 12301325 | Diarrhoea | |
123013255 | 12301325 | Drug ineffective | |
123013255 | 12301325 | Fibromyalgia | |
123013255 | 12301325 | Hepatic enzyme increased | |
123013255 | 12301325 | Neuropathy peripheral | |
123013255 | 12301325 | Osteoarthritis | |
123013255 | 12301325 | Osteopenia | |
123013255 | 12301325 | Pain | |
123013255 | 12301325 | Pain in extremity | |
123013255 | 12301325 | Poor venous access | |
123013255 | 12301325 | Rheumatoid arthritis | |
123013255 | 12301325 | Spinal column stenosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123013255 | 12301325 | 4 | 200711 | 201207 | 0 | |
123013255 | 12301325 | 5 | 2015 | 0 | ||
123013255 | 12301325 | 7 | 200701 | 200706 | 0 | |
123013255 | 12301325 | 11 | 201412 | 0 | ||
123013255 | 12301325 | 13 | 200706 | 200708 | 0 | |
123013255 | 12301325 | 15 | 200609 | 200802 | 0 | |
123013255 | 12301325 | 16 | 200803 | 201008 | 0 | |
123013255 | 12301325 | 18 | 201207 | 0 |